ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Dial Access Offers Caner Consultation Services

February 21, 1975

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988

MD Anderson Completes $500 Million Research Endowment

September 24, 2010

Other NCI funding opportunities listed.

July 9, 2004